522 Targeting HER2 with trastuzumab-DM1 (T-DM1) is highly effective in preclinical models of HER2-overexpressing bladder cancer

✍ Scribed by Hayashi, T.; Jäger, W.; Moskalev, I.; Awrey, S.; Li, N.; Fazli, L.; Yasui, W.; Matsubara, A.; Black, P.C.

• Book ID: 122235420
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 199 KB
• Volume: 13
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(14)60514-5